Araştırma Makalesi

Longitudinal Assessment of Alterations in Peripheral Inflammatory Markers Over a Hospitalization Period in Patients with Schizophrenia

Cilt: 33 Sayı: 6 31 Aralık 2023
PDF İndir
EN TR

Longitudinal Assessment of Alterations in Peripheral Inflammatory Markers Over a Hospitalization Period in Patients with Schizophrenia

Öz

Objective: To assess the effects of regular medication administration, diet, sleep, and physical activity provided by hospital care on inflammatory markers in schizophrenia patients. The primary hypothesis of our study is that the assembly of various factors, will reduce low-grade inflammation in a short period. Materials and Methods: This retrospective longitudinal study involved 106 patients diagnosed with schizophrenia who met the exclusion and inclusion criteria. Inflammatory markers such as neutrophil-to-lymphocyte Ratios (NLR), monocyte-to-lymphocyte ratios (MLR), platelet-to-lymphocyte ratios (PLR), C-reactive protein-to-albumin ratios (CAR), and systemic immune inflammation indices (SII) were calculated at the time of hospital admission and after three weeks. Results: The mean age of the participants was 39.0±13.1 years and the majority were male (n: 75). Reductions were observed in all inflammatory markers after three weeks. The CRP decreased from a median value of 2.6 (interquartile range (IQR): 1.1-5.3) to 1.90 (IQR: 0.85-3.30) (p=0.001, effect size=0.375). The CAR changed from 0.064 (IQR: 0.026-0.115) to 0.043 (IQR: 0.017-0.077) (p=0.005, effect size=0.371). The NLR demonstrated a significant reduction from 2.31 (IQR: 1.73-3.24) to 1.73 (IQR: 1.28-2.27) (p<0.001, effect size=0.647). The SII decreased from 634 (IQR: 425-870) to 470 (IQR: 321-645) (p<0.001, effect size=0.577). The PLR went down from 9.85 (IQR: 7.4-12.7) to 8.21 (IQR: 6.22-10.3) (p<0.001, effect size=0.547). Lastly, the MLR reduced from 0.297 (IQR: 0.221-0.378) to 0.258 (IQR: 0.195-0.319) (p<0.001, effect size=0.522). Conclusion: This study underscores the influence of regular antipsychotic treatment and hospital care in reducing inflammation markers like NLR, MLR, PLR, SII, and CAR in schizophrenia patients. Future studies should explore the potential of markers like CAR and SII in detecting low-grade inflammation, and further probe into the role of sleep, nutrition, and physical activity, emphasising the paramount role of comprehensive hospital care.

Anahtar Kelimeler

schizophrenia, low-grade inflammation, antipsychotics, systemic immune inflamattion index (SII), C-reaktive protein (CRP)- to-albumin ratio (CAR)

Kaynakça

  1. Soygür H. The concept of schizophrenia: ‘’Shall we destroy and rebuild, repair and update?’’ Update in Psychiatry, 2023; 13(1):1-9.
  2. Ermakov EA, Melamud MM, Buneva VN, Ivanova SA. Immune system abnormalities in schizophrenia: An integrative view and translational perspectives. Front Psychiatry, 2022; 25(13):880568.
  3. Zhu X, Zhou J, Zhu Y, Yan F, Han X, Tan Y, Li R. Neutrophil/lymphocyte, platelet/lymphocyte and monocyte/lymphocyte ratios in schizophrenia. Australas Psychiatry, 2022; 30(1):95-99.
  4. Tsai SJ. Role of interleukin 8 in depression and other psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry, 2021; 106:110173.
  5. Goldsmith DR, Rapaport MH, Miller BJ. A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression. Mol Psychiatry, 2016; 21(12):1696-1709.
  6. Jarskog LF, Xiao H, Wilkie MB, Lauder JM, Gilmore JH. Cytokine regulation of embryonic rat dopamine and serotonin neuronal survival in vitro. Int J Dev Neurosci. 1997 Oct;15(6):711-716.
  7. Rodrigues-Amorim D, Rivera-Baltanás T, Spuch C, Caruncho HJ, González-Fernandez Á, Olivares JM, et al. Cytokines dysregulation in schizophrenia: A systematic review of psychoneuroimmune relationship. Schizophr Res, 2018; 197:19-33.
  8. Bulut NS, Yorguner N, Çarkaxhiu Bulut G. The severity of inflammation in major neuropsychiatric disorders: comparison of neutrophil-lymphocyte and platelet-lymphocyte ratios between schizophrenia, bipolar mania, bipolar depression, major depressive disorder, and obsessive compulsive disorder. Nord J Psychiatry, 2021; 75(8):624-632.
  9. Inanli I, Aydin M, Çaliskan AM, Eren I. Neutrophil/lymphocyte ratio, monocyte/lymphocyte ratio, and mean platelet volume as systemic inflammatory markers in different states of bipolar disorder. Nord J Psychiatry. 2019;73(6):372-379.
  10. Huang K, Tang Y, Chen Z, Ding S, Zeng H, Zhao Y, Yu Q, Liu Y. Comparison of hematological parameters between first-episode schizophrenia and anti-NMDAR encephalitis. Front Cell Dev Biol, 2022; 10:895178.

Kaynak Göster

APA
Ozturk, H. I., Kurt, İ., Güçlü, O., & Dönmezler, S. (2023). Longitudinal Assessment of Alterations in Peripheral Inflammatory Markers Over a Hospitalization Period in Patients with Schizophrenia. Genel Tıp Dergisi, 33(6), 763-767. https://doi.org/10.54005/geneltip.1328023
AMA
1.Ozturk HI, Kurt İ, Güçlü O, Dönmezler S. Longitudinal Assessment of Alterations in Peripheral Inflammatory Markers Over a Hospitalization Period in Patients with Schizophrenia. Genel Tıp Derg. 2023;33(6):763-767. doi:10.54005/geneltip.1328023
Chicago
Ozturk, Halil Ibrahim, İmren Kurt, Oya Güçlü, ve Süleyman Dönmezler. 2023. “Longitudinal Assessment of Alterations in Peripheral Inflammatory Markers Over a Hospitalization Period in Patients with Schizophrenia”. Genel Tıp Dergisi 33 (6): 763-67. https://doi.org/10.54005/geneltip.1328023.
EndNote
Ozturk HI, Kurt İ, Güçlü O, Dönmezler S (01 Aralık 2023) Longitudinal Assessment of Alterations in Peripheral Inflammatory Markers Over a Hospitalization Period in Patients with Schizophrenia. Genel Tıp Dergisi 33 6 763–767.
IEEE
[1]H. I. Ozturk, İ. Kurt, O. Güçlü, ve S. Dönmezler, “Longitudinal Assessment of Alterations in Peripheral Inflammatory Markers Over a Hospitalization Period in Patients with Schizophrenia”, Genel Tıp Derg, c. 33, sy 6, ss. 763–767, Ara. 2023, doi: 10.54005/geneltip.1328023.
ISNAD
Ozturk, Halil Ibrahim - Kurt, İmren - Güçlü, Oya - Dönmezler, Süleyman. “Longitudinal Assessment of Alterations in Peripheral Inflammatory Markers Over a Hospitalization Period in Patients with Schizophrenia”. Genel Tıp Dergisi 33/6 (01 Aralık 2023): 763-767. https://doi.org/10.54005/geneltip.1328023.
JAMA
1.Ozturk HI, Kurt İ, Güçlü O, Dönmezler S. Longitudinal Assessment of Alterations in Peripheral Inflammatory Markers Over a Hospitalization Period in Patients with Schizophrenia. Genel Tıp Derg. 2023;33:763–767.
MLA
Ozturk, Halil Ibrahim, vd. “Longitudinal Assessment of Alterations in Peripheral Inflammatory Markers Over a Hospitalization Period in Patients with Schizophrenia”. Genel Tıp Dergisi, c. 33, sy 6, Aralık 2023, ss. 763-7, doi:10.54005/geneltip.1328023.
Vancouver
1.Halil Ibrahim Ozturk, İmren Kurt, Oya Güçlü, Süleyman Dönmezler. Longitudinal Assessment of Alterations in Peripheral Inflammatory Markers Over a Hospitalization Period in Patients with Schizophrenia. Genel Tıp Derg. 01 Aralık 2023;33(6):763-7. doi:10.54005/geneltip.1328023